Correction: Apatinib monotherapy for early non-small cell lung cancer: a case report

Correction: Apatinib monotherapy for early non-small cell lung cancer: a case report

Saved in:

Bibliographic Details
Main Authors:	Jiafang Xu, Qingjie Hu, Siqi Yin, Huifang He, Hai Li, Ruiqi Yang, Meizi Song, Chaoqun Wang, Yu Liu
Format:	Article
Language:	English
Published:	BMC 2024-11-01
Series:	Journal of Cardiothoracic Surgery
Online Access:	https://doi.org/10.1186/s13019-024-03134-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Apatinib monotherapy for early non-small cell lung cancer: a case report
by: Jiafang Xu, et al.
Published: (2024-10-01)

Effects of Apatinib on the “Stemness” of Non-Small-Cell Lung Cancer Cells In Vivo and Its Related Mechanisms
by: Bin Yang, et al.
Published: (2020-01-01)

A phase II study of antiangiogenic therapy (Apatinib) plus chemotherapy as second‐line treatment in advanced small cell lung cancer
by: Yinghui Xu, et al.
Published: (2023-02-01)

Clinical efficacy and safety of anti PD-1/PD-L1 antibodies as monotherapy in patients with non-small-cell lung cancer
by: Marta Zayas-Soriano, et al.
Published: (2021-01-01)

Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer
by: Hortense De Saint Basile, et al.
Published: (2024-12-01)

Liquid biopsy in detecting early non-small cell lung cancer
by: Rafael Rosell, et al.
Published: (2023-09-01)

Atezolizumab monotherapy as first-line treatment for non-small cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a cost-effectiveness analysis in the USA
by: Hui Lin, et al.
Published: (2024-11-01)

Crocin Monotherapy in Non-Central Diabetic Macular Edema
by: Mojtaba Mojtahedzadeh, et al.
Published: (2024-12-01)

Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trial
by: Guoshuang Shen, et al.
Published: (2025-02-01)

Correction: Involvement of TRPC Channels in Lung Cancer Cell Differentiation and the Correlation Analysis in Human Non-Small Cell Lung Cancer.
by: Hong-Ni Jiang, et al.
Published: (2024-01-01)

Correction: The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer
by: Julie Tsu-Yu Wu, et al.
Published: (2024-12-01)

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
by: Qiang Liu, et al.
Published: (2020-05-01)

Usefulness of perampanel as initial monotherapy in children with non-lesional focal epilepsy
by: Hideaki Kanemura, et al.
Published: (2025-03-01)

Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy
by: Hayato Kawachi, et al.
Published: (2025-12-01)

Analysis of the correlation between the dose exposure intensity and apatinib in advanced gastric cancer: a retrospective cohort study
by: Xiao Ma, et al.
Published: (2025-02-01)

Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: a single-arm phase 2 trial
by: Yu-Chun Zhu, et al.
Published: (2024-11-01)

Correction: Circulating Tumor cells and multiple indicators combined to identify the risk of poorer prognosis in patients with resected non-small cell lung cancer
by: Jinghan Song, et al.
Published: (2024-12-01)

Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second‐line monotherapy for patients with small‐cell lung cancer
by: Jieran Long, et al.
Published: (2024-09-01)

Comprehensive analysis of the prognostic and immunological role of cavins in non-small cell lung cancer
by: Kelin Mou, et al.
Published: (2024-12-01)

Effects of Ginsenoside Biopolymer Nanoparticles on the Malignant Behavior of Non-Small-Cell Lung Cancer
by: Weizheng Zhou, et al.
Published: (2020-01-01)

Long-term survival and failure patterns in inoperable early-stage non-small cell lung cancer following stereotactic body radiotherapy: a single-institution retrospective study
by: Lin Wang, et al.
Published: (2024-12-01)

Correction: Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial
Published: (2020-05-01)

Non–Small-Cell Lung Cancer. Unusual Small Bowel Metastasis with Invagination
by: Miguel Ángel Serra Valdés, et al.
Published: (2017-07-01)

Identification of nine mutant genes and establishment of three prediction models of organ tropism metastases of non‐small cell lung cancer
by: Shuchen Chen, et al.
Published: (2023-02-01)

Efficacy and Safety of the Combination of Transarterial Chemoembolization with Camrelizumab plus Apatinib for Advanced Hepatocellular Carcinoma: A Retrospective Study of 38 Patients from a Single Center
by: Jin-Xing Zhang, et al.
Published: (2022-01-01)

Link of apoptosis level in the primary tumor at early stages of non-small cell lung cancer with efficacy of adjuvant polychemotherapy
by: Kolesnik O.P., et al.
Published: (2013-12-01)

Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis
by: Jeff Clarke, et al.
Published: (2025-02-01)

Could serum Raftlin and GPER-1levels be new biomarkers for early detection of non-small cell lung cancer?
by: Aykut Eliçora, et al.
Published: (2025-01-01)

EPIC Array Study in Liquid Biopsy Identifies a Non-invasive Epigenetic Signature for Early Diagnosis in Non-small Cell Lung Cancer
by: J. Sandoval, et al.
Published: (2023-11-01)

Combination Use of Tegafur and Apatinib as First-Line Therapy in Treatment of Advanced Gastric Cancer: A Single-Blinded Randomized Study
by: Chaofeng Li, et al.
Published: (2020-01-01)

Rapid health technology assessment of anlotinib in treatment of advanced non-small cell lung cancer
by: Shan SHEN, et al.
Published: (2021-10-01)

Comprehensive review of LncRNA-mediated therapeutic resistance in non-small cell lung cancer
by: Xin Ge, et al.
Published: (2024-11-01)

Treating early-stage centrally-located non-small cell lung cancer with DCAT-SBRT in centers lacking the VMAT technique: a comprehensive study
by: Yangyang Huang, et al.
Published: (2024-12-01)

Recent advances in the treatment of non-small cell lung cancer with MET inhibitors
by: Dongna Zhang, et al.
Published: (2024-12-01)

Author Correction: Predicting the tumor microenvironment composition and immunotherapy response in non-small cell lung cancer from digital histopathology images
by: Sushant Patkar, et al.
Published: (2025-01-01)

Correction: Complete metabolic response in patients with advanced non-small cell lung cancer with prolonged response to immune checkpoint inhibitor therapy
Published: (2021-06-01)

Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy
by: Arash Maleki, et al.
Published: (2022-11-01)

The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer
by: Gaia Passarella, et al.
Published: (2025-01-01)

Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario Forum
by: Parneet K. Cheema, et al.
Published: (2024-11-01)

Biomarkers for immunotherapy resistance in non-small cell lung cancer
by: Catriona Rother, et al.
Published: (2024-12-01)